​Chong-xian Pan, MD, PhD, MS, is an Associate Professor of Medicine at Brigham and Women’s Hospital and Harvard Medical School.
​Dr. Pan is a medical oncologist, physician-scientist, and clinical investigator. His lab mainly focuses on translational research in bladder cancer, including drug development, patient-derived cancer models and immunotherapy. He has successfully translated his own preclinical studies into six investigator-initiated clinical trials, including organizing three GMP (Good Manufacturing Practice) formulations and IND (Investigational New Drug) applications.